جست‌وجوی استاد و پژوهشگر

Matthias W. Hentzeمشاهده پروفایل

مدرس پاره‌وقت

• Molecular Biology
• Molecular Medicine
• RNA Biology
• +۴ مورد دیگر

Matthias W. Hentze is a leading scientist in molecular biology and RNA research, holding key positions as Director and Senior Scientist at the European Molecular Biology Laboratory (EMBL) since 2013 and 1998, respectively. He is also a PartTime Lecturer at Ruprecht-Karls-University Heidelberg's Medical Faculty since 2005 and co-director of the Molecular Medicine Partnership Unit since 2002. His career spans roles as EMBL Associate Director (2005–2013), Dean of Graduate Studies (1996–2005), and Group Leader (1989–present). Education: M.D. from Westfaelische-Wilhelms-University Muenster (1984) and habilitation in Medical Molecular Biology at Heidelberg (1990). Dr. Hentze's research focuses on RNA biology, translational control, and iron homeostasis. He pioneered discoveries on RNA-binding proteins, iron-responsive elements, and microRNA-mediated translation inhibition. His work bridges molecular mechanisms with systemic metabolism regulation. His publications since 1987 highlight groundbreaking contributions to RNA structure-function relationships, translational control, and iron metabolism. Themes include microRNA mechanisms (2007), mRNA-binding proteomes (2012), and iron regulatory protein functions (1987, 1992, 1998). Scientific Awards: Otto Warburg Medal (2025), RNA Society Lifetime Achievement Award (2020), Leibniz Prize (2000), EMBO Membership (1997), and others.

Helen Rizosمشاهده پروفایل

استاد

• Melanoma
• Oncogenic Signaling
• Treatment Resistance
• +۳ مورد دیگر

Professor Helen Rizos is a leading academic at Macquarie University, holding roles as Principle Investigator of the Macquarie University Cancer Biobank and Head of the Precision Cancer Therapy research team within the Macquarie School of Medicine, Faculty of Medicine, Health and Human Sciences. She completed her PhD at Macquarie University and has been an independent group leader since 2000. Her research focuses on melanoma biology, treatment resistance, and liquid biomarkers, with over 170 publications and 9,218 citations. She leads key initiatives like the ACRF Centre for Advanced Cancer Modelling (COMET) and has received prestigious awards, including the Jim Piper Award for Research Leadership (2023). Education: Bachelor of Science (Honors I) from University of New South Wales PhD from Macquarie University Research Themes: Liquid biomarkers for treatment resistance prediction Mechanisms of therapy resistance in melanoma Development of novel cancer models Affiliations: Faculty member, Melanoma Institute Australia Principal Investigator, Macquarie University Cancer Biobank Her research has advanced understanding of ctDNA dynamics in melanoma prognosis, immunotherapy response, and targeted therapy resistance. Key projects include AI-driven cancer modeling (BioInnoMQ) and liquid biopsy applications for cancer care. Awards: Jim Piper Award for Excellence in Research Leadership (2023) Wildfire Highly Cited Publication Award (2017) Grants & Collaborations: ACRF Centre for Advanced Cancer Modelling (2024–2030) CRE-USYD Oral Cancer Excellence Centre (2024–2029) Labs/Teams: Leads the Precision Cancer Therapy team and collaborates with institutions like Westmead Institute for Medical Research and Melanoma Institute Australia.

• Cardiovascular Disease
• Molecular Biology
• Gene Regulation
• +۵ مورد دیگر

Ileana Badi is a Senior Postdoctoral Researcher at the University of Oxford, affiliated with the Antoniades Group (The Oxford Translational Cardiovascular Research Group). She holds a PhD from the University of Insubria (Italy, 2008) and has conducted postdoctoral work at the University of Amsterdam and the Centro Cardiologico Monzino in Milan. Her research focuses on cellular and molecular mechanisms underlying cardiovascular diseases, particularly the roles of transcription factors (Ankrd1, Tbx3), microRNAs (miR-34a, miR-92a-3p), and the cross-talk between adipose tissue and cardiovascular systems in inflammation, calcification, and redox signaling dysregulation. Education: PhD in Molecular Biology, University of Insubria (Italy), 2008 Research interests emphasize translational studies bridging basic science and clinical applications. Key areas include: MicroRNA-mediated vascular pathologies Adipose-tissue-cardiovascular crosstalk mechanisms Therapeutic targeting of inflammation and calcification pathways Redox signaling in atherosclerosis and myocardial disease Recent work highlights advancements in radiotranscriptomic signatures for vascular inflammation assessment (Lancet Digital Health, 2022) and insights into lipoprotein(a) genetics influencing cardiovascular outcomes (European Heart Journal, 2023). Her publications frequently integrate clinical data with molecular discoveries, aiming to improve cardiovascular disease management through novel biomarkers and drug mechanisms. No scientific awards have been explicitly mentioned. Her research is supported by collaborations within the Antoniades Group, though specific grants are not detailed in the text. She currently leads projects investigating adipose tissue interactions with the cardiovascular system and has no listed advisees. Labs/Teams: Active member of The Oxford Translational Cardiovascular Research Group, integrating clinical research with basic science to advance disease understanding and therapies.

• Virology
• Immunology
• Autoimmunity
• +۶ مورد دیگر

Dr. Sanjay Swaminathan is a Clinical Associate Professor at the University of Sydney's Westmead Clinical School, within the Department of Medicine (Immunology and Infectious Diseases). He holds leadership roles as Head of Immunology and Allergy at Westmead and Blacktown Hospitals. His expertise spans clinical practice, research, and teaching in immunology, allergy, and infectious diseases, with a focus on HIV, EBV, and autoimmune conditions. Swaminathan's research centers on viral-immune interactions, particularly how EBV modulates gene expression in autoimmune diseases and HIV pathogenesis. He leads the EBV Molecular Laboratory, employing experimental and computational methods to explore therapeutic targets. His work includes miRNA studies linking EBV to immune dysregulation and gender-based disease disparities. Education: PhD on HIV-1 miRNA research under Prof. Anthony Kelleher, followed by postdoctoral training at the Frederick National Laboratory for Cancer Research. Teaching: Modules in AMED 3003 and AMED 3888 courses. International Collaborations: France (INSERM on miR-155) and the USA (Frederick National Lab on HIV-IL-27 mechanisms). His recent publications (2023) highlight breakthroughs in Sjögren’s syndrome biomarkers, neuropsychiatric lupus diagnostics, and EBV-MS genetic interactions. He has secured grants from Multiple Sclerosis Research Australia targeting EBV-based therapies. Awards: FAAAAAI (2023), ASCIA membership. Grants: Over $500k in funding for EBV therapeutic strategies and MS research since 2019. His lab explores innovative treatments like siRNA targeting EBV proteins and investigates gender-specific immune responses in autoimmunity.

Jessamy Tiffenمشاهده پروفایل

مدرس ارشد

• Cancer Biology
• Epigenetics
• Melanoma
• +۳ مورد دیگر

Dr. Jessamy Tiffen is an Adjunct Senior Lecturer at the University of Sydney's School of Medical Sciences and Head of the Melanoma Epigenetics Laboratory at the Centenary Institute. She holds an Honorary Senior Research Fellowship at the Faculty of Medicine and Health. Her research focuses on epigenetic modifiers in melanoma, particularly mechanisms driving resistance to treatment, sex-based survival disparities, and immune response modulation. Her current projects include investigating X-linked epigenetic regulators' role in male melanoma mortality, identifying epigenetic drivers of drug resistance, enhancing immunotherapy efficacy via epigenetic targeting, and understanding melanoma dedifferentiation. She has secured grants from organizations like Cancer Council NSW and Therapeutic Innovations Australia. Key awards include the 2021 Cancer Institute NSW Career Development Fellowship and the 2020 The Educator Rising Star Award. Her work spans over 30 peer-reviewed publications, with recent contributions exploring BET protein inhibition and X chromosome-linked survival advantages. Dr. Tiffen advises students in Honours, Masters, and PhD programs, focusing on translational research with clinical impact. She leads a multidisciplinary team at the Centenary Institute's Melanoma Immunology and Oncology Program, emphasizing gender equity and graduate mentoring.

• Reproductive Biology
• Molecular Biology
• Embryology
• +۳ مورد دیگر

Dr. Sophea Heng is a Research Fellow in the Department of Health and Biomedical Sciences at RMIT University. Her research focuses on molecular mechanisms regulating endometrial receptivity and embryo implantation, with implications for fertility treatment. Current supervision projects include studies on endometrial epithelial cells and trophoblast differentiation. She holds an ORCID identifier (0000-0001-9570-8746) and is based at the Bundoora West campus. Key Research Areas: Reproductive biology, molecular biology of implantation, microRNA regulation Supervision: Molecular understanding of endometrial cells (2024), Trophoblast differentiation (2022) Her work investigates proteins like podocalyxin and hormonal pathways (e.g., progesterone) affecting endometrial function. Findings have clinical relevance for improving IVF success rates and understanding implantation failure mechanisms.

• Cardiovascular Disease
• Metabolic Disorders
• Sympathetic Nervous System
• +۴ مورد دیگر

Elisabeth Lambert is a Senior Research Fellow at Swinburne University of Technology, affiliated with the School of Health Science and the Iverson Health Innovation Research Institute. She previously worked at the Baker Heart and Diabetes Institute for 18 years. Her research focuses on cardiovascular and metabolic diseases, particularly the role of the sympathetic nervous system in conditions like hypertension, obesity, type-2 diabetes, and intellectual disability-related cardiometabolic risks. She has published over 220 papers and secured 12 NHMRC grants. Recent achievements include refining techniques for identifying brain areas linked to muscle sympathetic nerve activity and demonstrating links between sympathetic activity and vascular aging in anorexia nervosa patients. Education: PhD from the University of Paris, France. Research Interests: Mechanisms of cardiovascular and metabolic disorders, sympathetic nervous system regulation, clinical applications of neuroimaging (MEG, MRI), and translational research in hypertension and obesity. Key areas include stress-induced cardiovascular responses, renal denervation efficacy, and the impact of loneliness on vascular health. Publications: Recent work highlights brain-sympathetic interactions in stress, long-term outcomes of renal denervation, and the role of microRNAs in metabolic diseases. Articles span neurophysiology, cardiovascular risk factors, and translational clinical studies. Advising & Grants: Supervised 7 PhD students on topics like brain pathways in hypertension, vagus nerve stimulation, and cardiometabolic risks in intellectual disability. NHMRC grants support her research on sympathetic nervous system dysregulation. Labs/Teams: MedTechVic and the Iverson Health Innovation Research Institute, focusing on interdisciplinary health solutions.

Babukrishna Maniyadathمشاهده پروفایل

پژوهشگر

• Metabolic Regulation
• Epigenetics
• Adipose Tissue Biology
• +۳ مورد دیگر

Babukrishna Maniyadath is a Researcher at the University of Southern Denmark (SDU), affiliated with the Susanne Mandrup Lab. He holds a PhD from the Tata Institute of Fundamental Research (TIFR), Mumbai, India (2020), and specializes in metabolic regulation, epigenetics, and adipose tissue biology. His current research focuses on adipose tissue plasticity during obesity development and regression, employing single-cell transcriptomics, cytometry, and primary cell culture techniques. Key research themes include molecular mechanisms governing in-vivo adipogenesis under high-fat diets, metabolic oscillations in liver physiology, and the interplay between nutrient signaling and epigenetic modifications. Dr. Maniyadath's work bridges basic science with translational applications in obesity and metabolic disorders. Publications emphasize single-cell resolution analysis of adipose tissue dynamics, chromatin regulation under metabolic stress, and SIRT1/SIRT6 signaling pathways. His research has implications for understanding obesity pathogenesis and developing therapeutic strategies targeting metabolic plasticity. No scientific awards are explicitly listed. He collaborates with the Mandrup Lab on projects involving functional genomics and metabolism, contributing to the ATLAS project's adipose tissue atlas initiative.

• Reproductive Endocrinology
• Infertility
• Pediatric and Adolescent Gynecology
• +۶ مورد دیگر

Dr. Amanda N. Kallen serves as Associate Professor of Obstetrics and Gynecology at the Yale School of Medicine. She is a member of the Reproductive Scientist Development Program (RSDP) and leads the Kallen Lab, which focuses on reproductive science. Dr. Kallen is actively involved with numerous programs including the Center for RNA Science and Medicine, Fertility Preservation Program, In Vitro Fertilization Program, Pediatric & Adolescent Gynecology, and Recurrent Pregnancy Loss Program. Dr. Kallen completed her medical education at the University of Connecticut School of Medicine (MD, 2007), followed by residency in Obstetrics and Gynecology at Yale-New Haven Hospital (2010), where she served as Administrative Chief Resident (2011). She then completed her fellowship in Reproductive Endocrinology and Infertility at Yale School of Medicine (2014). During her fellowship, she was accepted into the NIH-funded Reproductive Scientist Development Program scholar program. Dr. Kallen's research program investigates the regulation of gene expression in granulosa cells, with specific interests in Granulosa Cells, Gynecology, Infertility, MicroRNAs, Ovary, Reproductive Medicine, and RNA, Long Noncoding. Her work spans reproductive biology, molecular mechanisms of ovarian function, and clinical applications for fertility preservation. Dr. Kallen has published extensively in high-impact journals including New England Journal of Medicine, Fertility and Sterility, and Human Reproduction, with recent publications focusing on premature ovarian insufficiency, ovarian tissue cryopreservation, and cellular mechanisms of ovarian aging. Dr. Kallen has received multiple awards including the Yale University "Resident of Excellence" award, the North American Menopause Society / Teva Medical Resident Excellence Award, the American Society of Reproductive Medicine (ASRM) Resident Reporter award, and the Association of Professors of Gynecology and Obstetrics Resident Scholar award. Dr. Kallen is highly active in professional organizations, currently serving on the Executive Board of the American Congress of Obstetricians and Gynecologists (ACOG) as the national Junior Fellow Congress Advisory Council Chair. She is a graduate of ACOG's Robert Cefalo Leadership Institute and a member of the ASRM Women's Council. Dr. Kallen also serves as an Interactive Associate for Fertility & Sterility and as a reviewer for multiple scientific journals. As an educator, Dr. Kallen plays an active role in medical student and resident education and serves as a faculty mentor for the Yale medical student Ob/Gyn Interest Group. Her clinical interests include pediatric and adolescent gynecology and endocrinology, infertility, and premature ovarian insufficiency.

• Epigenetics
• Endocrinology
• Cardiovascular Disease
• +۳ مورد دیگر

Da Li is an Adjunct Associate Professor at Yale School of Medicine. His research focuses on epigenetics, cardiovascular diseases, diabetes, and reproductive medicine. He collaborates extensively with experts in endocrinology and molecular biology, contributing to studies on vascular endothelial injury mechanisms and therapeutic interventions. Key projects include investigating TET3’s role in endometriosis and insulin resistance, as well as developing bioengineering approaches for endometrial research. His work bridges basic science and clinical applications, with a focus on translational medicine. Dr. Li’s publications highlight advancements in understanding lipid metabolism during embryonic development, the role of microRNAs in liver fibrosis, and the efficacy of atorvastatin in vascular protection. He is a co-author of expert consensus guidelines on oocyte vitrification, emphasizing his contributions to reproductive health. His interdisciplinary approach involves collaborations with departments across Yale, reflecting a commitment to addressing complex biological systems and clinical challenges.

• Molecular Biology
• RNA Processing
• Developmental Biology
• +۳ مورد دیگر

Vanessa Mondol is an Associate Research Scientist at Yale University's Molecular Biophysics and Biochemistry Department, affiliated with the Yale School of Medicine. She holds a PhD in Biology from the University of California, San Diego (2015). Her research focuses on molecular mechanisms of RNA processing, microRNA regulation, and developmental biology in Caenorhabditis elegans. Mondol's work integrates genetic, biochemical, and genomic approaches to study post-transcriptional gene regulation and its role in organismal development. Key research interests include: MicroRNA biogenesis and function RNA interference pathways Developmental timing mechanisms Post-transcriptional control of gene expression Her publications (2010–2015) explore topics like Drosha processing of primary microRNAs, synthetic genetic systems for evolutionary engineering, and RNA binding protein regulation of developmental miRNAs. No awards or grants are explicitly listed in available records.

Jaimy Saifمشاهده پروفایل

مدرس

• Vascular Biology
• Angiogenesis
• Therapeutic Angiogenesis
• +۴ مورد دیگر

Jaimy Saif is a Lecturer in Biomedical Sciences at Aston University, affiliated with the Aston Medical School and the College of Health and Life Sciences. Their research focuses on vascular regeneration, including therapeutic angiogenesis and pre-eclampsia. Dr. Saif holds a PhD in Cancer Immunotherapy from Nottingham Trent University and has extensive postdoctoral experience across institutions like Ludwig Maximilian University of Munich and the University of Nottingham. Education: PhD (Cancer Immunotherapy, Nottingham Trent University 2014), MSc (Stem Cell Technology, University of Nottingham 2008), BSc (Biotechnology, Bangalore University 2007). Professional qualifications include SFHEA (2024) and MED (2024). Research interests span vascular biology, microRNA regulation, and translational therapies for ischemic disorders and maternal hypertension. Key projects include investigating hydrogen sulfide-based therapies for preeclampsia and exosome-mediated mechanisms in diabetic vascular complications. Publications highlight work on stem cell-derived endothelial therapies, BDNF-driven differentiation pathways, and miRNA modulation in cell survival. Their work bridges basic science and clinical applications, aiming to influence medical practice through translational research. Honors include Senior Fellow of the Higher Education Academy (SFHEA), recognizing contributions to medical education. Dr. Saif leads cardiovascular modules in the MBChB program and oversees Phase I assessments at Aston Medical School.

Richard Pestellمشاهده پروفایل

استاد

• Cancer Therapy
• Oncology
• Cell Cycle Regulation
• +۵ مورد دیگر

Richard Pestell is the Blumberg Distinguished Professor at Thomas Jefferson University and President of the Pennsylvania Cancer and Regenerative Medicine Center. He has led major cancer centers, including the Lombardi Comprehensive Cancer Center and Sidney Kimmel Cancer Center. A clinician-scientist, he holds MBBS, MD, PhD, and MBA degrees, with expertise in oncology, endocrinology, and cell cycle regulation. His research focuses on cancer therapy, tumor heterogeneity, and drug development, contributing to clinical trials of CDK inhibitors and CCR5 antagonists. He has published over 700 works and received prestigious awards, including Officer of the Order of Australia for contributions to medicine and education. Dr. Pestell has secured $86 million in grants and founded six biotechnology companies, advancing cancer diagnostics and therapeutics. Education: MBBS (University of Western Australia), MD/PhD (Melbourne University), MBA (NYU Stern) Leadership Roles: Past President of INCTR (global cancer nonprofit), founding Director of Delaware Valley Institute for Clinical and Translational Science Research Interests: Key areas include cyclin D1’s role in breast cancer, CCR5 inhibitors for metastasis, and translational oncology. His work bridges basic science and clinical applications, influencing FDA-approved treatments. Awards: RD Wright Medallion, Eric Susman Prize, and dual Honoris Causa degrees. Grants & Impact: Principal Investigator of NIH grants totaling over $86 million, with patents in cancer diagnostics and therapies.

Kostas Tokatlidisمشاهده پروفایل

استاد

• Mitochondria biogenesis
• Protein targeting and import
• Protein folding and assembly
• +۴ مورد دیگر

Professor Kostas Tokatlidis is the Cathcart Chair of Biochemistry and Director of Research in the School of Molecular Biosciences at the University of Glasgow, where he heads the Mitochondria Biology Laboratory. He is an elected Member of EMBO, Academia Europaea, Fellow of the Royal Society of Edinburgh (FRSE), Royal Society of Chemistry (FRSC) and Royal Society of Biology (FRSB). Education & Training PhD in Biochemical Engineering, University of Delaware, USA (1988–1993) – Fulbright Fellow Post-doctoral fellowships: Institut Pasteur, France (1993–1994); Biozentrum, Switzerland (1994–1998) First-class BSc in Chemical Engineering, Aristotle University of Thessaloniki, Greece Major research interests Mitochondrial biogenesis and protein import pathways Oxidative protein folding and redox signalling Molecular chaperones and membrane protein assembly Stress responses, metabolism and ageing Iron–sulfur cluster biogenesis and disease links Scientific awards & honours 2022 – Member, Academia Europaea 2021 – Fellow, Royal Society of Chemistry (FRSC) 2020 – Fellow, Royal Society of Biology (FRSB) 2016 – Fellow, Royal Society of Edinburgh (FRSE) 2013 – EMBO Member & Royal Society Wolfson Research Merit Award 2012 – Greek Ministry of Education Excellence Grant 2001 – Lister Institute Research Fellow & MRC Career Establishment Award 1988 – Fulbright Fellow Advising & Grant leadership He has mentored 25 PhD/graduate students and 17 post-doctoral researchers and has served as Director of Graduate/Undergraduate Studies and Director of Research in the School of Molecular Biosciences. His group has secured >€12 million in competitive funding from 43 UK/EU grants, including current awards such as the 2025-2031 EPSRC MAINSTREAM Hub, MRC Mitotrapin and BBSRC partnership grants. Laboratory & facilities Professor Tokatlidis leads the Mitochondria Biology Laboratory and the Mitochondrial Analysis Facility at the University of Glasgow, coordinates the Scottish Healthy Ageing and Mitochondria & Redox Biology research networks, and fosters interdisciplinary collaborations across Europe and globally.

Carla Pezziaمشاهده پروفایل

دانشیار

• Global Health
• Health Disparities
• Cultural Dimensions of Mental Illness
• +۳ مورد دیگر

Carla Pezzia is an Associate Professor of Biology at the University of Dallas. She holds a B.A. from the University of North Texas, an M.P.H. from the University of North Texas Health Science Center, and a Ph.D. from the University of Texas at San Antonio. Her research focuses on global health, health disparities, cultural dimensions of mental illness, alcoholism recovery, and Latin America, with a methodological emphasis on applied anthropological research. Dr. Pezzia is affiliated with the UT Health Science Center at San Antonio through a community assistance research collaboration. Her professional memberships include the Society for Applied Anthropology and the American Anthropology Association. She has held academic leadership roles such as Chair of the Human Rights and Social Justice Committee (2013–2015) and Member-at-Large of the National Association for the Practice of Anthropology Governing Council (2015–2017). Her recent courses include Conceptual Foundations of Human Sciences , Global Public Health , and Peoples of Latin America , reflecting her interdisciplinary approach to health and cultural studies. Her publications span observational studies on healthcare team dynamics, qualitative research on mental health stigma in Guatemala, and investigations into the social determinants of food and economic insecurity. Dr. Pezzia’s work bridges anthropological theory with practical health interventions, particularly in underserved populations. Her research often addresses how cultural contexts influence healthcare access and recovery processes, with a focus on marginalized communities in Latin America and the U.S.